Methenamine mandelate: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
==Category== | ==Category== | ||
Urinary anti-infective | |||
==US Brand Names== | ==US Brand Names== | ||
Revision as of 09:20, 9 January 2014
| Methenamine mandelate |
|---|
| METHENAMINE MANDELATE® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Category
Urinary anti-infective
US Brand Names
METHENAMINE MANDELATE®
FDA Package Insert
Description | Clinical Pharmacology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
An acid urine is essential for antibacterial action, with maximum efficacy occurring at pH 5.5 or less. In an acid urine, mandelic acid exerts its antibacterial action and also contributes to the acidification of the urine.[1]
References
- ↑ "METHENAMINE MANDELATE TABLET [EDENBRIDGE PHARMACEUTICALS, LLC]". Text " accessdate" ignored (help)